| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP 7384 7385 7386 Rx only | 7 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP 7384 7385 7386 Rx only | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | These highlights do not include all the information needed to use divalproex sodium extended-release tablets safely and effectively. See full prescribing information for divalproex sodium extended-release tablets. Divalproex Sodium Extended-release Tablets, USP for oral use Initial U.S. Approval: 2000 | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | These highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-release Capsules, USP INITIAL U.S. APPROVAL: 1989 | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES 7384 7385 7386 Rx only | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES 7384 7385 7386 Rx only | 6 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | PRODUCT INFORMATION Cefuroxime Axetil Tablets, USP | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | These highlights do not include all the information needed to use verapamil hydrochloride extended-release capsules (PM) safely and effectively. See full prescribing information for verapamil hydrochloride extended-release capsules (PM). Verapamil Hydrochloride Extended-release Capsules (PM) (Controlled Onset) for Oral use Initial U.S. Approval: 1998 | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | b3180408-a3c0-4e02-8535-dea390a52277 | 7 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | These highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-Release Capsules, USP Initial U.S. Approval: 1989 | 3 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | These highlights do not include all the information needed to use levetiracetam extended-release tablets safely and effectively. See full prescribing information for levetiracetam extended-release tablets. LEVETIRACETAM extended-release tablets for oral use Initial U.S. Approval: 1999 | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | RX Only | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | These highlights do not include all the information needed to use tamsulosin hydrochloride capsules safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. Tamsulosin Hydrochloride Capsules, 0.4 mg Initial U.S. Approval: 1997 | 3 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | These highlights do not include all the information needed to use APLENZIN safely and effectively. See full prescribing information for APLENZIN. APLENZIN (bupropion hydrobromide) tablet, film coated, extended release for oral use Initial U.S. Approval: 1985 | 1 | |
| dibutyl sebacate | INACTIVE INGREDIENT | 4W5IH7FLNY | ULTRAM ® ER (tramadol HCl) Extended-Release Tablets | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES - CII | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | Metadate CD ® (methylphenidate HCl, USP) Extended-Release Capsules CII | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | These highlights do not include all the information needed to use divalproex sodium extended-release tablets safely and effectively. See full prescribing information for divalproex sodium extended-release tablets for oral administration. Divalproex Sodium Extended-release Tablets Initial U.S. Approval: 2000 | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | These highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-Release Capsules, USP Initial U.S. Approval: 1989 | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | 322513fd-6be0-4cd9-a0ea-7e4b5b578336 | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | RX Only | 1 | |
| dibutyl sebacate | INACTIVE INGREDIENT | 4W5IH7FLNY | 3b95acd8-1cce-4b76-9cb2-6e9ea40e54b1 | 1 | |
| dibutyl sebacate | INACTIVE INGREDIENT | 4W5IH7FLNY | ULTRAM ER (TRAMADOL HYDROCHLORIDE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3685 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VENLAFAXINE HYDROCHLORIDE TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3320 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | TRAMADOL HYDROCHLORIDE (TRAMADOL HYDROCHLORIDE) TABLET, EXTENDED RELEASE TRAMADOL HYDROCHLORIDE (TRAMADOL HYDROCHLORIDE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3040 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DIVALPROEX SODIUM (DIVALPROEX SODIUM ) TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ] | 113 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DIVALPROEX SODIUM (DIVALPROEX SODIUM ) TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ] | 107 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX EXTENDED-RELEASE (HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX) SUSPENSION, EXTENDED RELEASE [ARISTOS PHAMACEUTICALS, INC.] | 17 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DIVALPROEX SODIUM TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 14 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | LUVOX CR (FLUVOXAMINE MALEATE) CAPSULE, EXTENDED RELEASE [JAZZ PHARMACEUTICALS, INC.] | 14 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [SANDOZ INC] | 14 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VERAPAMIL HYDROCHLORIDE PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 14 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DIVALPROEX SODIUM TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 13 | |
| dibutyl sebacate | INACTIVE INGREDIENT | 4W5IH7FLNY | METADATE CD (METHYLPHENIDATE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [UNITHER MANUFACTURING, LLC] | 13 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] | 13 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | APLENZIN (BUPROPION HYDROBROMIDE) TABLET, EXTENDED RELEASE [SANOFI-AVENTIS U.S. LLC] | 12 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | EMBEDA (MORPHINE SULFATE AND NALTREXONE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC] | 12 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | LAMISIL (TERBINAFINE HYDROCHLORIDE) GRANULE [NOVARTIS PHARMACEUTICALS CORPORATION] | 12 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [MYLAN PHARMACEUTICALS INC.] | 12 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 12 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DEXEDRINE SPANSULE (DEXTROAMPHETAMINE SULFATE) CAPSULE, EXTENDED RELEASE [AMEDRA PHARMACEUTICALS LLC] | 11 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DELZICOL (MESALAMINE) CAPSULE, DELAYED RELEASE [WARNER CHILCOTT (US), LLC] | 10 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | TRAMADOL HYDROCHLORIDE TABLET, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.] | 9 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DEXTROAMPHETAMINE SULFATE CAPSULE, EXTENDED RELEASE [BARR LABORATORIES INC.] | 8 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | KETOPROFEN CAPSULE KETOPROFEN CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 8 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE] | 8 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 8 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 7 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DIVALPROEX SODIUM CAPSULE, DELAYED RELEASE [MYLAN PHARMACEUTICALS INC.] | 7 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DULOXETINE HYDROCHLORIDE (DULOXETINE HYDROCHLORIDE ) CAPSULE, DELAYED RELEASE DULOXETINE HYDROCHLORIDE (DULOXETINE HYDROCHLORIDE ) CAPSULE, DELAYED RELEASE [APOTEX CORP.] | 7 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | GALANTAMINE HYDROBROMIDE CAPSULE, EXTENDED RELEASE GALANTAMINE TABLET, FILM COATED [BARR LABORATORIES INC.] | 7 | |
| Dibutyl sebacate | INACTIVE INGREDIENT | 4W5IH7FLNY | URSO 250 (URSODIOL) TABLET, FILM COATED URSO FORTE (URSODIOL) TABLET, FILM COATED [APTALIS PHARMA US, INC.] | 7 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE (DEXTROAMPHETAMINE SULFATE) CAPSULE, EXTENDED RELEASE [LINEAGE THERAPEUTICS] | 6 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DIVALPROEX SODIUM TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.] | 6 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | METHYLPHENIDATE HYDROCHLORIDE (CD) (METHYLPHENIDATE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] | 6 | |
| dibutyl sebacate | INACTIVE INGREDIENT | 4W5IH7FLNY | METHYLPHENIDATE HYDROCHLORIDE CD (METHYLPHENIDATE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 6 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [CARDINAL HEALTH] | 6 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [MYLAN INSTITUTIONAL INC.] | 6 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | TAMSULOSIN HYDROCHLORIDE CAPSULE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.] | 6 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | URSODIOL TABLET [GLENMARK PHARMACEUTICALS INC., USA] | 6 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE] | 5 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.] | 5 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | ELEPSIA XR (LEVETIRACETAM) TABLET, EXTENDED RELEASE [SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED] | 5 | |
| dibutyl sebacate | INACTIVE INGREDIENT | 4W5IH7FLNY | TRAMADOL HYDROCHLORIDE TABLET, EXTENDED RELEASE [PATRIOT PHARMACEUTICALS, LLC] | 5 | |
| dibutyl sebacate | INACTIVE INGREDIENT | 4W5IH7FLNY | URSO (URSODIOL) TABLET, FILM COATED [CARDINAL HEALTH] | 5 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 4 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DIVALPROEX SODIUM EXTENDED RELEASE (DIVALPROEX SODIUM EXTENDED RELEASE) TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ] | 4 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] | 4 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | POTASSIUM CHLORIDE CAPSULE, EXTENDED RELEASE [PADDOCK LABORATORIES, LLC] | 4 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 4 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | TRAMADOL HYDROCHLORIDE TABLET, EXTENDED RELEASE [LUPIN PHARMACEUTICALS, INC.] | 4 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | TRAMADOL HYDROCHLORIDE TABLET, EXTENDED RELEASE [UNIT DOSE SERVICES] | 4 | |
| dibutyl sebacate | INACTIVE INGREDIENT | 4W5IH7FLNY | ULTRAM ER (TRAMADOL HYDROCHLORIDE) TABLET, EXTENDED RELEASE [JANSSEN PHARMACEUTICALS, INC.] | 4 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | COLESTIPOL HYDROCHLORIDE TABLET, FILM COATED [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.] | 3 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DILACOR XR (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.] | 3 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 3 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH] | 3 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ] | 3 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DIVALPROEX SODIUM TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ] | 3 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DIVALPROEX SODIUM TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH] | 3 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | FENOFIBRIC ACID CAPSULE, DELAYED RELEASE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 3 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [MAJOR PHARMACEUTICALS] | 3 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 3 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.] | 3 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | APLENZIN (BUPROPION HYDROBROMIDE) TABLET, EXTENDED RELEASE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | CEFUROXIME AXETIL TABLET, FILM COATED [UNIT DOSE SERVICES] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DELZICOL (MESALAMINE) CAPSULE, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ST MARYS MEDICAL PARK PHARMACY] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DIVALPROEX SODIUM CAPSULE [MYLAN INSTITUTIONAL INC.] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DIVALPROEX SODIUM TABLET, FILM COATED, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DULOXETINE HYDROCHLORIDE CAPSULE, DELAYED RELEASE [PREFERRED PHARMACEUTICALS, INC.] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DULOXETINE HYDROCHLORIDE CAPSULE, DELAYED RELEASE [PROFICIENT RX LP] | 2 | |
| Dibutyl Sebacate | INACTIVE INGREDIENT | 4W5IH7FLNY | HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX SUSPENSION, EXTENDED RELEASE [NEOS THERAPEUTICS, LP] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE) TABLET, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [GOLDEN STATE MEDICAL SUPPLY] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [MCKESSON CONTRACT PACKAGING] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | TAMSULOSIN HYDROCHLORIDE (TAMSULOSIN HYDROCHLORIDE) CAPSULE [REMEDYREPACK INC. ] | 2 | |
| dibutyl sebacate | INACTIVE INGREDIENT | 4W5IH7FLNY | ULTRAM ER (TRAMADOL HYDROCHLORIDE) TABLET [REMEDYREPACK INC. ] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | URSODIOL TABLET [ACTAVIS PHARMA, INC.] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MCKESSON PACKAGING SERVICES A BUSINESS UNIT OF MCKESSON CORPORATION] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [PROFICIENT RX LP] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [PROFICIENT RX LP] | 2 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | CEFUROXIME AXETIL TABLET, FILM COATED [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | CEFUROXIME AXETIL TABLET, FILM COATED [CLINICAL SOLUTIONS WHOLESALE] | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | CEFUROXIME AXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | CEFUROXIME AXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | CEFUROXIME AXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | CEFUROXIME AXETIL TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.] | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | CEFUROXIME AXETIL TABLET, FILM COATED [WOCKHARDT LIMITED] | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | CEFUROXIME AXETIL TABLET, FILM COATED [WOCKHARDT USA LLC.] | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DEXTROAMPHETAMINE SULFATE CAPSULE, EXTENDED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ] | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ] | 1 | |
| DIBUTYL SEBACATE | INACTIVE INGREDIENT | 4W5IH7FLNY | DIVALPROEX SODIUM TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ] | 1 | |